Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease atrial fibrillation
Phenotype C0018824|valvular heart disease
Sentences 9
PubMedID- 20550616 Background: the purpose of this study is to evaluate the efficacy of atrial fibrillation (af) ablation in patients with moderate valvular heart disease (vhd).
PubMedID- 26261514 Therefore, we hypothesized that synd4 shedding was also involved in the inflammatory response in atrial fibrillation patients with valvular heart disease.
PubMedID- 23465222 Objectives: the aim of this study was to determine whether altered calreticulin expression and distribution contribute to the pathogenesis of atrial fibrillation (af) associated with valvular heart disease (vhd).
PubMedID- 21287469 New procedure for treatment of atrial fibrillation in patients with valvular heart disease.
PubMedID- 23631185 [atrial fibrillation concomitant with valvular heart disease].
PubMedID- 22547769 Aims: the aim of this study was to determine whether altered expression and distribution of calcium- and integrin-binding protein-1 (cib1) is involved in the pathogenesis of different types of patients with atrial fibrillation (af) associated with valvular heart disease (vhd).
PubMedID- 24431682 The indications were valvular heart disease with valve replacement, atrial fibrillation, or thrombus in 60 % patients; chronic deep vein thrombosis (dvt) in 7 % patients; thrombophilia in 9.1 % patients; recurrent pregnancy losses in 18 % patients; and dvt prophylaxis in 5.5 % patients.
PubMedID- 22263119 Background: we evaluated the efficacy of cox-maze iv procedure using bipolar irrigated radiofrequency ablation and cryothermy in chronic atrial fibrillation associated with valvular heart disease.
PubMedID- 23781350 Acute atrial fibrillation in valvular heart disease has a high risk of heart failure, stroke, and death [6].

Page: 1